Nottingham, United Kingdom

Jon Heal

This inventor holds 1 USPTO granted patent. Top assignee: Takasago International Corporation. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jon Heal. Retrieved from https://idiyas.com/inventor/jon-heal-8l32krkz

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jon Heal - Innovator in Macrocyclic Ketone Production

Introduction

Jon Heal is a notable inventor based in Nottingham, GB. He has made significant contributions to the field of biotechnology, particularly in the production of macrocyclic ketones. His innovative work has implications for various applications in the chemical and pharmaceutical industries.

Latest Patents

Jon Heal holds a patent for the "Production of macrocyclic ketones in recombinant hosts." This invention relates to recombinant microorganisms and methods for producing macrocyclic ketones and their precursors. His patent showcases his expertise in utilizing biotechnology to enhance production processes.

Career Highlights

Jon Heal is associated with Takasago International Corporation, where he applies his knowledge and skills to advance the company's research and development efforts. His work at Takasago has positioned him as a key player in the field of macrocyclic compounds.

Collaborations

Throughout his career, Jon has collaborated with esteemed colleagues, including Curt Aimé Friis Nielsen and Johannes Haerle. These partnerships have fostered innovation and contributed to the success of various projects.

Conclusion

Jon Heal's contributions to the production of macrocyclic ketones highlight his role as an influential inventor in biotechnology. His work continues to impact the industry positively, paving the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…